Form 4: WBA Director Shrank Receives Phantom Stock Grant

Walgreens Boots Alliance director William H. Shrank received 16,820.86 phantom stock units as part of his annual non-employee director compensation.

Summary

• Director William H. Shrank of Walgreens Boots Alliance, Inc. (WBA) acquired 16,820.86 phantom stock units.
• The acquisition occurred on August 13, 2025, as part of the annual phantom stock grant for non-employee director compensation.
• These units compensate for services rendered over the prior year and are issued under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan.
• Each phantom stock unit is the economic equivalent of one share of WBA common stock, with an implied value of $11.89 per unit.
• The units are scheduled to be settled following the termination of Shrank's service as a director, in accordance with the Plan's terms and conditions.

Sentiment

Score: 7

Explanation: The filing indicates a routine, expected compensation event for a director, aligning their interests with shareholders through equity. This is generally a neutral to slightly positive signal as it reflects standard corporate governance and director retention practices.

Positives

• The grant aligns director compensation with shareholder interests through equity-based incentives.
• It reflects ongoing compensation for services rendered by a non-employee director, a standard corporate governance practice.

Future Outlook

The phantom stock units are to be settled following the termination of service as a director, indicating a long-term retention mechanism for the director.

Industry Context

This is a routine compensation disclosure for a director of a large retail pharmacy chain. It reflects standard corporate governance practices for non-employee director compensation, often involving equity-linked instruments to align interests with shareholders.

Comparison to Industry Standards

• Granting equity-based compensation like phantom stock units to non-employee directors is a common practice across large publicly traded companies, including those in the retail pharmacy and healthcare sectors.
• Companies like CVS Health (CVS) and Rite Aid (RAD) also utilize various forms of equity compensation for their directors to incentivize long-term performance and alignment.
• The specific value and number of units would typically be benchmarked against peer companies' director compensation packages, though this filing does not provide such comparative data.

Corporate Governance

Related Party Transactions

• The acquisition of phantom stock units by Director William H. Shrank from Walgreens Boots Alliance, Inc. constitutes a related party transaction, specifically a compensation event.

Stakeholder Impact

• Shareholders: Director's interests are further aligned with shareholders through equity ownership, potentially fostering long-term value creation.

Next Steps

• Settlement of phantom stock units will occur upon termination of William H. Shrank's service as a director.

Key Dates

Recommendation

This Form 4 filing details a routine compensation event for a non-employee director, involving the grant of phantom stock units. Such a transaction is standard practice for public companies to align director interests with shareholder value and does not typically indicate a significant change in the company's fundamental outlook or operations. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Walgreens Boots Alliance, WBA, Form 4, SEC filing, phantom stock, director compensation, equity grant, insider transaction, William H. Shrank